# Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients

> **NCT04912687** · NA · COMPLETED · sponsor: **Institut Bergonié** · enrollment: 581 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Advanced Solid Tumor

## Interventions

- **DIAGNOSTIC_TEST:** EGFR gene mutation analysis on liquid biopsy

## Key facts

- **NCT ID:** NCT04912687
- **Lead sponsor:** Institut Bergonié
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2026-01-17
- **Final completion:** 2026-01-17
- **Target enrollment:** 581 (ACTUAL)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04912687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04912687, "Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04912687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*